Celyad Oncology S.A.
CYADNASDAQHealthcare
$0.47
$-0.07(-12.96%)
Market Cap$14238462
P/E Ratio—
52W High$3.07
52W Low$0.15
Celyad Oncology S.A. (CYAD) Stock Splits
No forward or reverse splits on record since IPO — details below.
FMP · CYAD · as of May 18, 2023
Key split metrics
—
Celyad Oncology S.A. (CYAD) has been publicly traded since Jun 19, 2015 with no forward or reverse splits on record.
About stock split history
Celyad Oncology S.A. (CYAD) has never undergone a stock split since going public.
Frequently asked questions
Celyad Oncology S.A. (CYAD) has never split its stock since going public.
CYAD stock split historyhas CYAD ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.